Full video transcriptClick to expand
Auto-generated transcript of @armonadibi's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00My TRT is 220 milligrams a week if I want bigger gains in fat loss
- 0:06What would be a good amount to increases to I do get blood worked? Okay? I would go to 500
- 0:11And that should give you really really good gains. You might just want to
- 0:17Watch your estrogen and you might have to adjust your anti estrogen if you're
- 0:21Producing too much and it's getting a little too high
- 0:24But besides that of course watch your you know
- 0:27Red blood count make sure you're donating blood if you need it some people don't need to donate
- 0:31Okay, not everybody needs to donate just watch that and you'll get really really good gains with 500 and
- 0:38You can stay on that for about you know, you can stay on testosterone
- 0:43You know higher amounts for longer periods of time
- 0:45Let's say you can do that for six months and then go back down to your regular TRT dose good luck man
TRT and bodybuilding contest prep: separating protocol from hype
Quick answer
The video advises a person already on 220mg/week of testosterone to increase to 500mg/week for body composition goals, framing this as a temporary cycle before returning to a standard TRT dose. At 500mg/week, testosterone is well into supraphysiologic territory associated with HDL suppression, erythrocytosis, and potential cardiac remodeling, risks not addressed in the video. Any dose adjustment of exogenous testosterone should occur under direct provider supervision with baseline and follow-up labs including lipids, hematocrit, blood pressure, and estradiol.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT and bodybuilding contest prep: separating protocol from hype, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
TRT and bodybuilding contest prep: separating protocol from hype should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT and bodybuilding contest prep: separating protocol from hype" from Armon Adibi. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video advises a person already on 220mg/week of testosterone to increase to 500mg/week for body composition goals, framing this as a temporary cycle before returning to a standard TRT dose.
The reason this review is not generic is the source wording and the canonical claim label "trt answer to lkwitter78 sad figure bodybuilding coach contestpr." In this clip, the useful excerpt is: "My TRT is 220 milligrams a week if I want bigger gains in fat loss What would be a good amount to increases to I do get blood worked?" That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The video advises a person already on 220mg/week of testosterone to increase to 500mg/week for body composition goals, framing this as a temporary cycle before returning to a standard TRT dose.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video advises a person already on 220mg/week of testosterone to increase to 500mg/week for body composition goals, framing this as a temporary cycle before returning to a standard TRT dose. At 500mg/week, testosterone is well into supraphysiologic territory associated with HDL suppression, erythrocytosis, and potential cardiac remodeling, risks not addressed in the video. Any dose adjustment of exogenous testosterone should occur under direct provider supervision with baseline and follow-up labs including lipids, hematocrit, blood pressure, and estradiol.
- 500mg of testosterone per week is a supraphysiologic, performance-enhancing dose, not a modified TRT dose, and the distinction matters clinically.
- Bhasin et al. (1996, NEJM) confirmed dose-dependent anabolic effects of testosterone, but those subjects were under controlled monitoring, not self-directing based on social media advice.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- 500mg of testosterone per week is a supraphysiologic, performance-enhancing dose, not a modified TRT dose, and the distinction matters clinically.
- Bhasin et al. (1996, NEJM) confirmed dose-dependent anabolic effects of testosterone, but those subjects were under controlled monitoring, not self-directing based on social media advice.
- Coviello et al. (2008, JCEM) found that doses above approximately 300mg per week significantly suppress HDL cholesterol, a cardiovascular risk the creator did not address.
- Long-term supraphysiologic androgen exposure is associated with left ventricular hypertrophy and adverse cardiac remodeling per Rasmussen et al. (2016, European Heart Journal).
- Hematocrit monitoring and blood donation are legitimate clinical tools for managing erythrocytosis, but they address only one of several serious risks at this dose level.
- Any adjustment to an exogenous testosterone regimen requires provider-supervised labs including lipids, hematocrit, blood pressure, estradiol, and PSA for appropriate candidates.
- HPG axis suppression at 500mg per week means return to baseline after cycling down is not guaranteed to be smooth, particularly in long-term testosterone users.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @armonadibi actually say?
The creator responded to a follower who is already on 220mg of testosterone per week and wants bigger gains and more fat loss. The advice was direct: jump to 500mg per week, watch estrogen, possibly adjust an anti-estrogen, monitor red blood cell count, donate blood if needed, and stay at that higher dose for about six months before returning to a standard TRT dose. The phrase "really really good gains" was used twice, framing this as a reliable, low-drama upgrade.
This is not a gray area. A licensed provider recommending 220mg per week is already operating above what most endocrinology guidelines consider standard TRT. Advising an internet stranger to more than double that dose, based on no labs and no clinical intake, is a different category of risk entirely.
Does the science back this up?
The pharmacology is real, but the framing strips out the actual risk profile. Yes, higher testosterone doses produce more muscle and less fat. That part is documented. But the safety picture at 500mg per week looks nothing like the one at a supervised TRT dose.
A landmark NEJM study by Bhasin et al. (1996) showed dose-dependent muscle gains at supraphysiologic testosterone levels, but those subjects were monitored in a controlled setting. More relevant is the work of Coviello et al. (2008, Journal of Clinical Endocrinology and Metabolism), which demonstrated that testosterone doses above approximately 300mg per week substantially suppress HDL cholesterol, a cardiovascular risk factor that the creator did not mention at all. Rasmussen et al. (2016, European Heart Journal) and related research have linked long-term supraphysiologic androgen use to left ventricular hypertrophy and adverse cardiac remodeling. The creator's mention of monitoring hematocrit and donating blood is not wrong, but it addresses one risk while leaving cardiovascular, lipid, and hepatic considerations completely unaddressed.
What did they get wrong (or right)?
Credit where it is due: mentioning estrogen management and hematocrit monitoring reflects real clinical considerations. These are things providers actually track. Acknowledging that not everyone needs to donate blood is also accurate, individual response varies.
But here is what went wrong, and it matters. First, 500mg per week is not a TRT dose. It is a performance-enhancing dose used in bodybuilding cycles. Calling it a temporary increase before returning to "your regular TRT dose" blurs that line in a way that could lead someone to normalize pharmacological androgen use as routine hormone optimization. Second, no lipid panel discussion. No blood pressure mention. No acknowledgment that six months at 500mg per week is a meaningful cardiovascular exposure. Third, and most important, this advice was given to a stranger on TikTok with no clinical history, no recent labs reviewed on screen, and no provider relationship established. The creator says "I do get blood worked" as if that checkbox clears the path for a dose more than doubling.
What should you actually know?
If you are on TRT and want to optimize body composition, the conversation belongs with a prescribing provider who has your actual labs, not a TikTok comment section. Here is what that conversation should include.
- Hematocrit and hemoglobin, because supraphysiologic testosterone increases red blood cell mass and raises clotting risk.
- A full lipid panel. HDL suppression at higher doses is well-documented and cardiac risk accumulates silently.
- Blood pressure. Testosterone affects fluid retention and vascular tone.
- Estradiol levels, not just the assumption that an anti-estrogen might be needed.
- PSA if you are over 40.
The idea that you can run 500mg per week for six months and simply step back down to a TRT dose with no consequence is not supported by the pharmacology. Recovery of the hypothalamic-pituitary-gonadal axis at that suppression level is not guaranteed to be clean or fast, especially in someone already on exogenous testosterone long-term. A regulated telehealth provider can help you understand what optimization actually looks like within a monitored, legal framework.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Armon Adibi · TikTok creator
42.0K views on this video
#answer to @lkwitter78 #sad #figure #bodybuilding #coach #contestprep #seromax #ifbb #npc #dietitian #fittok #adibiarmy #love #bestfriend #mma #powerlifting #npcjudge #winners #mensphysique #classicphysique #trt #hgh #hrt #wpd #health #death #driven #contestprep #natty #fakeinfluencer #fakecoaches #enhanced #supplementsthatwork #dominate
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about 500mg of testosterone per week?
500mg of testosterone per week is a supraphysiologic, performance-enhancing dose, not a modified TRT dose, and the distinction matters clinically.
What does the video say about bhasin et al. (1996, nejm) confirmed dose-dependent anabolic effects of?
Bhasin et al. (1996, NEJM) confirmed dose-dependent anabolic effects of testosterone, but those subjects were under controlled monitoring, not self-directing based on social media advice.
What does the video say about coviello et al. (2008, jcem) found?
Coviello et al. (2008, JCEM) found that doses above approximately 300mg per week significantly suppress HDL cholesterol, a cardiovascular risk the creator did not address.
What does the video say about long-term supraphysiologic?
Long-term supraphysiologic androgen exposure is associated with left ventricular hypertrophy and adverse cardiac remodeling per Rasmussen et al. (2016, European Heart Journal).
What does the video say about hematocrit monitoring?
Hematocrit monitoring and blood donation are legitimate clinical tools for managing erythrocytosis, but they address only one of several serious risks at this dose level.
What does the video say about any adjustment to an exogenous testosterone regimen requires provider-supervised labs?
Any adjustment to an exogenous testosterone regimen requires provider-supervised labs including lipids, hematocrit, blood pressure, estradiol, and PSA for appropriate candidates.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Armon Adibi, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.